KRYSTAL BIOTECH INC (KRYS) Stock Balance Sheet
NASDAQ:KRYS • US5011471027
Current stock price
245.39 USD
-6.01 (-2.39%)
At close:
245.39 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 496.30M | 344.87M | 358.33M | 161.90M | 341.20M | |||
| Marketable Securities | 331.49M | 252.65M | 173.85M | 217.30M | 96.90M | |||
| Receivables | 127.42M | 104.75M | 42.04M | N/A | N/A | |||
| Inventories | 40.48M | 26.51M | 6.99M | N/A | N/A | |||
| Other Current Assets | 28.91M | 13.27M | 6.71M | 4.60M | 4.20M | |||
| Total Current Assets | 1.02B | 742.04M | 587.91M | 383.80M | 442.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 158.01M | 161.45M | 168.23M | 169.70M | 119.60M | |||
| Investments And Advances | 128.07M | 152.11M | 61.95M | 4.60M | 64.40M | |||
| Other Non-Current Assets | 23.11M | 231.00K | 263.00K | 300.00K | 100.00K | |||
| Total Non-Current Assets | 309.19M | 313.79M | 230.45M | 174.70M | 184.00M | |||
| TOTAL ASSETS | 1.33B | 1.06B | 818.36M | 558.50M | 626.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 85.21M | 90.32M | 24.47M | 24.60M | 17.20M | |||
| Accounts Payable | 3.24M | 4.99M | 4.13M | 4.00M | 8.40M | |||
| Other Current Liabilities | 14.50M | 6.69M | 4.49M | 300.00K | 200.00K | |||
| Total Current Liabilities | 102.94M | 102.00M | 33.09M | 28.80M | 25.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 11.29M | 7.46M | 6.62M | 7.40M | 7.00M | |||
| Total Non-Current Liabilities | 11.29M | 7.46M | 6.62M | 7.40M | 7.00M | |||
| TOTAL LIABILITIES | 114.23M | 109.46M | 39.71M | 36.20M | 32.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 24.16M | -180.67M | -269.83M | -280.80M | -140.80M | |||
| Additional Paid In Capital | 1.19B | 1.13B | 1.05B | 803.70M | 734.50M | |||
| Common Shares | 300.00 | 300.00 | 300.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 1.14M | -190.30K | 637.70K | -700.00K | -200.00K | |||
| Shares Outstanding | 29.19M | 28.79M | 28.24M | 25.80M | 25.20M | |||
| Tangible Book Value per Share | 41.78 | 32.87 | 27.58 | 20.24 | 23.56 | |||
| Total Shareholders' Equity | 1.22B | 946.38M | 778.64M | 522.20M | 593.60M | |||
| TOTAL LIABILITIES AND EQUITY | 1.33B | 1.06B | 818.36M | 558.50M | 626.30M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 9.95 | 7.28 | 17.76 | 13.33 | 17.21 | |||
| Return On Assets (ROA) | 15.36% | 8.44% | 1.34% | -25.06% | -11.11% | |||
| Return On Equity (ROE) | 16.80% | 9.42% | 1.40% | -26.81% | -11.72% | |||
| Return On Invested Capital (ROIC) | 10.35% | 8.55% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 31.61% | 22.88% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 31.61% | 22.88% | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21